References

1. Dean B, Barber N, Schachter M. What is a prescribing error? BMJ Quality & Safety. 2000;9(4):232-7.
2. Organization WH. Medication errors: World Health Organization; 2016.
3. Organization WH. Medication without harm: WHO’s third global patient safety challenge. . 2017.
4. Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JF, Kos M. PCNE definition of medication review: reaching agreement. International journal of clinical pharmacy. 2018;40(5):1199-208.
5. Ravn-Nielsen LV, Duckert M-L, Lund ML, Henriksen JP, Nielsen ML, Eriksen CS, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA internal medicine. 2018;178(3):375-82.
6. Huiskes VJB, Burger DM, van den Ende CHM, van den Bemt BJF. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC family practice. 2017;18:1-15.
7. Bos JM, Natsch S, van den Bemt P, Pot JLW, Nagtegaal JE, Wieringa A, et al. A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals. Int J Clin Pharm. 2017;39(6):1211-9.
8. Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80(4):808-17.
9. Saedder EA, Brock B, Nielsen LP, Bonnerup DK, Lisby M. Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol. 2014;70(6):637-45.
10. Alanazi M, Tully M, Lewis P. A systematic review of the prevalence and incidence of prescribing errors with high‐risk medicines in hospitals. Journal of clinical pharmacy and therapeutics. 2016;41(3):239-45.
11. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Archives of internal medicine. 2008;168(17):1890-6.
12. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj. 2004;329(7456):15-9.
13. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. British journal of clinical pharmacology. 2007;63(2):136-47.
14. Blum MR, Sallevelt BT, Spinewine A, O’Mahony D, Moutzouri E, Feller M, et al. Optimizing therapy to prevent avoidable hospital admissions in Multimorbid older adults (OPERAM): cluster randomised controlled trial. bmj. 2021;374.
15. Fijn R, Van den Bemt PM, Chow M, De Blaey CJ, De Jong-Van den Berg LT, Brouwers JR. Hospital prescribing errors: epidemiological assessment of predictors. Br J Clin Pharmacol. 2002;53(3):326-31.
16. Cornuault L, Mouchel V, Phan Thi T-T, Beaussier H, Bézie Y, Corny J. Identification of variables influencing pharmaceutical interventions to improve medication review efficiency. International Journal of Clinical Pharmacy. 2018;40:1175-9.
17. Saedder EA, Lisby M, Nielsen LP, Rungby J, Andersen LV, Bonnerup DK, Brock B. Detection of patients at high risk of medication errors: development and validation of an algorithm. Basic & clinical pharmacology & toxicology. 2016;118(2):143-9.
18. Deawjaroen K, Sillabutra J, Poolsup N, Stewart D, Suksomboon N. Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug‐related problems: A systematic review of clinical prediction models and risk assessment tools. British Journal of Clinical Pharmacology. 2022;88(4):1613-29.
19. Mahomedradja RF, Sigaloff KC, Bekema JK, Dekker MJ, Brinkman DJ, Kuijvenhoven MA, et al. The pharmacotherapy team: A novel strategy to improve appropriate in‐hospital prescribing using a participatory intervention action method. British Journal of Clinical Pharmacology. 2021;87(2):565-76.
20. Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG, Lie AHL, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174.
21. Bosma L, Jansman FG, Franken AM, Harting JW, Van den Bemt PM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31-8.
22. Beuscart J-B, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC medicine. 2018;16(1):1-9.
23. Mahomedradja RF, van den Beukel TO, van den Bos M, Wang S, Kalverda KA, Lissenberg-Witte BI, et al. Prescribing errors in post-COVID-19 patients: prevalence, severity, and risk factors in patients visiting a post-COVID-19 outpatient clinic. BMC emergency medicine. 2022;22(1):1-12.
24. Alqenae F, Steinke D, Keers R. Prevalence and nature of medication errors and medication related harm immediately following hospital discharge from hospital to community settings: A systematic review. Pharmacoepidemiology and Drug Safety. 2019;28(S1):4-5.
25. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. Jama. 1995;274(1):29-34.
26. Wu PE, Lee TC, McDonald EG. What Should I Know About Medication Deprescribing? JAMA Internal Medicine. 2023.
27. Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’with network analysis: implications for future research and clinical practice. British journal of clinical pharmacology. 2015;80(6):1254-68.
28. Reumerman MO, Tichelaar J, Richir MC, van Agtmael MA. Medical students as junior adverse drug event managers facilitating reporting of ADRs. British Journal of Clinical Pharmacology. 2021;87(12):4853-60.
29. Mahomedradja RF, Schinkel M, Sigaloff KC, Reumerman MO, Otten RH, Tichelaar J, van Agtmael MA. Factors influencing in‐hospital prescribing errors: A systematic review. British Journal of Clinical Pharmacology. 2023.
30. Tully MP. Prescribing errors in hospital practice. British journal of clinical pharmacology. 2012;74(4):668-75.
31. Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. Jama. 2011;306(8):840-7.
32. Organization WH. Global strategy on human resources for health: workforce 2030. 2016.
33. Kaufmann CP, Stampfli D, Mory N, Hersberger KE, Lampert ML. Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems. BMJ Open. 2018;8(3):e016610.
34. Hollnagel E. Safety–I and safety–II: the past and future of safety management: CRC press; 2018.
35. Verhagen MJ, de Vos MS, Sujan M, Hamming JF. The problem with making Safety-II work in healthcare. BMJ Quality & Safety. 2022;31(5):402-8.
36. Lynn J, Schall MW, Milne C, Nolan KM, Kabcenell A. Quality improvements in end of life care: insights from two collaboratives. The Joint Commission journal on quality improvement. 2000;26(5):254-67.
37. Downar J, Goldman R, Pinto R, Englesakis M, Adhikari NK. The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. Cmaj. 2017;189(13):E484-E93.
38. White N, Kupeli N, Vickerstaff V, Stone P. How accurate is the ‘Surprise Question’ at identifying patients at the end of life? A systematic review and meta-analysis. BMC Medicine. 2017;15(1):139.
39. van Lummel EVTJ, Ietswaard L, Zuithoff NPA, Tjan DHT, van Delden JJM. The utility of the surprise question: A useful tool for identifying patients nearing the last phase of life? A systematic review and meta-analysis. Palliative Medicine. 2022;36(7):1023-46.
40. Weissman DE, Meier DE. Identifying patients in need of a palliative care assessment in the hospital setting a consensus report from the Center to Advance Palliative Care. Journal of palliative medicine. 2011;14(1):17-23.